










All three are GLP-1 medications that work by mimicking a natural hormone in your body to regulate appetite and food intake.
Wegovy (semaglutide) is injected weekly and targets a single hormone pathway (GLP-1) — it could help you lose up to 20% of your body weight. Mounjaro (tirzepatide) is also injected weekly, but targets two hormone pathways (GLP-1 and GIP), which may result in greater weight loss — up to 22%. Victoza (liraglutide) is injected daily, targets GLP-1 only, and could help you lose up to 10% of your body weight.
Individual results vary and depend on how well you stick to your treatment plan and make lifestyle changes alongside it.
Adults 18+ with a BMI of ≥ 27.5 (or ≥ 23 with certain health risks). Doctor confirmation is required.
Gradual dose taper + ongoing nutrition and exercise lowers rebound risk.
Adequate protein intake and resistance exercise helps preserve lean muscle mass.
Common side effects include nausea, diarrhoea, constipation, vomiting, injection site reactions, and low blood sugar. More serious side effects may occur and should be discussed with your doctor.
Common side effects include: Nausea, vomiting, diarrhoea, constipation, abdominal pain, headache.
Common side effects include: Nausea, vomiting, diarrhoea, constipation, abdominal pain, headache.
Common side effects include: Nausea, vomiting, diarrhoea, constipation, abdominal pain, headache.